We are live on ! Find out more
VOYA Investment Management

VOYA Investment Management Portfolio holdings

AUM $96.1B
1-Year Est. Return 40.06%
This Fund
S&P 500
This Quarter Est. Return
+5.62%
1 Year Est. Return
+40.06%
3 Year Est. Return
+122.14%
5 Year Est. Return
+169.19%
10 Year Est. Return
+659.21%
AUM
$101B
AUM Growth
+$1.26B
Cap. Flow
-$9.17B
Cap. Flow %
-9.04%
Top 10 Hldgs %
28.7%
Holding
2,500
New
68
Increased
791
Reduced
1,204
Closed
92

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$651M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$405M
3
KO icon
Coca-Cola
KO
+$293M
4
GEV icon
GE Vernova
GEV
+$284M
5
ASML icon
ASML
ASML
+$257M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$772M
2
ORCL icon
Oracle
ORCL
+$710M
3
NFLX icon
Netflix
NFLX
+$437M
4
MSFT icon
Microsoft
MSFT
+$342M
5
NOW icon
ServiceNow
NOW
+$312M

Sector Composition

Rank Sector Weight
1 Technology 35.32%
2 Financials 9.18%
3 Healthcare 9.01%
4 Industrials 8.5%
5 Consumer Discretionary 7.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FATE icon
2326
Fate Therapeutics
FATE
$319M
$22.1K ﹤0.01%
22,502
ALEC icon
2327
Alector
ALEC
$233M
$21.7K ﹤0.01%
13,929
HAIN icon
2328
Hain Celestial
HAIN
$48.8M
$20.2K ﹤0.01%
18,838
SPWR icon
2329
SunPower Inc
SPWR
$48.1M
$19.9K ﹤0.01%
12,674
EXFY icon
2330
Expensify
EXFY
$211M
$18.9K ﹤0.01%
12,539
ARAY icon
2331
Accuray
ARAY
$34.6M
$17.7K ﹤0.01%
21,433
ADV icon
2332
Advantage Solutions
ADV
$387M
$17.3K ﹤0.01%
784
ELDN icon
2333
Eledon Pharmaceuticals
ELDN
$289M
$17.2K ﹤0.01%
11,420
BRCC icon
2334
BRC Inc
BRCC
$212M
$16.9K ﹤0.01%
15,185
DCGO icon
2335
DocGo
DCGO
$57.4M
$16.4K ﹤0.01%
18,733
ATYR
2336
aTyr Pharma
ATYR
$52.4M
$13K ﹤0.01%
16,594
AKRO
2337
DELISTED
Akero Therapeutics
AKRO
-409,539
Closed -$19.4M
ALE
2338
DELISTED
Allete
ALE
-10,288
Closed -$683K
AMN icon
2339
AMN Healthcare
AMN
$1.28B
-15,435
Closed -$299K
ASH icon
2340
Ashland
ASH
$3.42B
-30,191
Closed -$1.45M
ASTE icon
2341
Astec Industries
ASTE
$989M
-4,300
Closed -$207K
ATLC icon
2342
Atlanticus Holdings
ATLC
$1.42B
-7,876
Closed -$461K
ATXS
2343
DELISTED
Astria Therapeutics
ATXS
-24,590
Closed -$179K
AVDX
2344
DELISTED
AvidXchange
AVDX
-30,668
Closed -$305K
AVNS
2345
DELISTED
Avanos Medical
AVNS
-138,233
Closed -$1.6M
BBCP icon
2346
Concrete Pumping Holdings
BBCP
$470M
-27,178
Closed -$192K
BBSI icon
2347
Barrett Business Services
BBSI
$761M
-5,121
Closed -$227K
BIDU icon
2348
Baidu
BIDU
$35.9B
-15,380
Closed -$2.03M
BMO icon
2349
Bank of Montreal
BMO
$127B
-22,450
Closed -$2.93M
BOKF icon
2350
BOK Financial
BOKF
$8.75B
-1,843
Closed -$205K

Similar funds

VOYA Investment Management's Q4 2025 Portfolio in Review

As of Q4 2025, VOYA Investment Management held 2,500 positions worth $101B, up 1.3% from $100B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

VOYA Investment Management withdrew a net $9.17B in Q4 2025, closing 92 positions and reducing 1,204 holdings. Its most notable exit was CoreWeave, an estimated $111M position sold in full.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.

Against the trend, VOYA Investment Management opened a new position in Invesco S&P 500 Equal Weight ETF worth $219M.

  • VOYA Investment Management's largest Q4 2025 buy was Invesco S&P 500 Equal Weight ETF: 1,141,275 shares worth $219M.
  • VOYA Investment Management added most to Eli Lilly in Q4 2025, an estimated $651M increase.
  • VOYA Investment Management's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $772M.
  • VOYA Investment Management fully exited CoreWeave in Q4 2025, selling an estimated $111M.
  • VOYA Investment Management's ten largest holdings make up 29% of its $101B portfolio in Q4 2025.
  • VOYA Investment Management opened 68 new positions and closed 92 in Q4 2025.
  • VOYA Investment Management's portfolio value rose 1.3% quarter-over-quarter to $101B.

Based on VOYA Investment Management's 13F filing for Q4 2025, filed 12 Feb 2026.